⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2024

Supplementary Data 1 from Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer

Whitney L. Hensing Lorenzo Gerratana Katherine Clifton Arielle J. Medford Marko Velimirovic Ami N. Shah Paolo D’Amico Carolina Reduzzi Qiang Zhang Charles S. Dai Elyssa N. Denault Nusayba A. Bagegni Mateusz Opyrchal Foluso O. Ademuyiwa Ron Bose Amir Behdad X. Cynthia Aditya Bardia Massimo Cristofanilli Andrew A. Davis

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

HER2 subtype and genomic alterations for all patients

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hensing et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587522ef1 https://doi.org/10.1158/1078-0432.27032095.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Data 1 from Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer2024
2Supplemental Figure 2 from Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer2024
3Supplemental Figure 2 from Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer2024
4Data from Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer2024
5Supplemental Figure 1 from Genetic alterations detected by circulating tumor DNA in HER2-low metastatic breast cancer2024